# Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

> **NCT02617069** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 170 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **BIOLOGICAL:** botulinum toxin injection
- **BIOLOGICAL:** 0.9% normal saline injection
- **DEVICE:** Implantable loop recorder

## Key facts

- **NCT ID:** NCT02617069
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-03
- **Final completion:** 2018-03
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2017-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617069, "Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02617069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*